Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cells, images of bacteria or viruses, DNA helixesSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales, images de bactéries ou de virus, hélices d'ADN

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

27 . 3 . 1

Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an objectLettres ou chiffres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet

27 . 3 . 2

Letters or numerals representing a human being or a part of the human bodyLettres ou chiffres représentant un être humain ou une partie du corps humain

Trademark usage description

protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, pharmaceutical preparations for use in immunology, n Read More

Classification Information

Class [005]
Protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, pharmaceutical preparations for use in immunology, namely, for the treatment of immunological disorders, oncology including immuno-oncology, for the treatment of cardiovascular and metabolic diseases, and for the treatment of infectious diseases, namely, respiratory infections; protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer, autoimmune and inflammatory diseases including transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases and orphan diseases; protein therapeutics namely, pharmaceutical preparations for use in immunology, namely, for the treatment of immunological disorders, rheumatology, namely, for the treatment of rheumatism, oncology including immuno-oncology, pulmonology, namely, for the treatment of respiratory diseases and disorders, gastroenterology, endocrinology, namely, for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, dermatology, namely, for the treatment of dermatitis, eczema, psoriasis, urology, namely, for the treatment of urological diseases, gynecology, namely, for the treatment of gynecological conditions, including fertility, infectiology, including virology namely, for the treatment of viral infections, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), ophthalmology, hepatology namely, for the treatment of hepatological diseases and disorders, neurology, namely, for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy and geriatrics, namely, for the treatment of geriatric diseases, namely, arthritis, osteoporosis, hypertension; protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer and autoimmune disorders, cytokines, interferons, tumor cell targeting and cytolytic agents, tolerogenic and antiallergic factors, growth and differentiation factors, hormones, replacement enzymes, coagulation factors, lipid binding proteins, protein factors for manufacturing of adoptive cell therapy products, anti-infectives, pain killers, and tissue repair factors; modified protein to be used in connection with a variety of therapeutic areas, namely protein arrays for medical diagnostic purposes; pharmaceutical preparations, namely, synthetic proteins for use in immunology, namely, for the treatment of immunological disorders, rheumatology, namely, for the treatment of rheumatism, oncology including immuno-oncology, pulmonology, namely, for the treatment of respiratory diseases and disorders, gastroenterology, endocrinology, namely, for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, dermatology, namely, for the treatment of dermatitis, eczema, psoriasis, urology, namely, for the treatment of urological diseases, gynecology, namely, for the treatment of gynecological conditions, including fertility, infectiology, including virology namely, for the treatment of viral infections, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), ophthalmology, hepatology namely, for the treatment of hepatological diseases and disorders, neurology, namely, for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy and geriatrics, namely, for the treatment of geriatric diseases, namely, arthritis, osteoporosis, hypertension

Classification kind code

Class [042]
Medical research; scientific research in the field of DNA; pharmaceutical research and development; laboratory research services in the field of pharmaceuticals; pharmaceutical research in the field of protein therapeutics; pharmaceutical research in the fields of immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, geriatrics, genetics and phenomics, pathology and forensics, proteomics and veterinary medicine and diagnostics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using a semi-synthetic organism for use in drug development; pharmaceutical research, namely, research relating to synthetic proteins incorporating one or more non-natural amino acids for improving pharmacological properties; pharmaceutical research, namely, research relating to synthetic proteins for use in connection with a wide variety of therapeutic agents

Classification kind code

Mark Details

Serial Number

2066757

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 30^th Mar 2022	Search Recorded
Submitted for opposition 20 on 30^th Mar 2022	Examiner's First Report
Submitted for opposition 223 on 30^th Mar 2022	Total Provisional Refusal
Submitted for opposition 256 on 27^th Sep 2021	Notification of Possible Opposition Sent
Submitted for opposition 48 on 04^th Mar 2021	Agent Changed
Submitted for opposition 31 on 30^th Nov 2020	Formalized
Submitted for opposition 1 on 30^th Nov 2020	Created
Submitted for opposition 257 on 26^th Nov 2020	Designation Notification - Madrid Protocol
Submitted for opposition 228 on 10^th Jul 2020	International Registration
Submitted for opposition 30 on 10^th Jul 2020	Filed